This work reports the anti-plasmodial activities of Warburgia ugandensis and Zanthoxylum usambarense commonly used as phytomedicines against malaria by some Kenyan communities. AIM OF STUDY:To determine the anti-plasmodial activities of extracts from Warburgia ugandensis and Zanthoxylum usambarense against Plasmodium knowlesi and Plasmodium berghei. MATERIALS AND METHODS:Eight plant extracts were screened for in vitro anti-plasmodial activity against Plasmodium knowlesi, in a 96-well plate incubated at 37 degrees C on a RPMI culture medium supplemented with baboon serum. Of the eight, three were investigated for prophylactic and curative activities in BALB/c mice against drug-sensitive Plasmodium berghei in a 4-day test at a dose rate of 200mg/kg/day. RESULTS:Inhibitory concentrations (IC(50)) values of between 3.14 and 75 microg/ml, up to 69% chemosuppression of parasites growth and over 80% survivorship of treated mice were observed. CONCLUSION:The two medicinal plants, Warburgia ugandensis and Zanthoxylum usambarense possess bioactive compounds against malaria parasites and could be exploited for further development into malaria therapy.

BackgroundTungiasis is a parasitic skin disease brought about by female Tunga penetrans when they burrow into the skin of their hosts. It is a disease that has largely been ignored. Epidemiology of tungiasis has not been widely studied in Kenya which could negatively affect effective intervention strategies. This study therefore sought to investigate epidemiology of tungiasis in selected areas in Kiharu constituency, Murang’a County in Kenya.MethodsThe study population comprised of public primary school pupils, the most vulnerable age group (n = 508) in Gaturi, Kimathi, Kahuhia and Mugoiri in Kiharu constituency. Public primary school pupils in the study area were randomly sampled. Through questionnaires and observations, data was collected.ResultsThe overall prevalence of tungiasis in pupils in the study area was 19.1 %. In multinomial logistic regression analysis some factors were identified to be associated with tungiasis such as lack of regular use of closed foot ware (Adjusted odds ratio = 10.45; 95 % Confidence Interval; 1.49–73.23), living in earthen mud walled houses (aOR = 13.78; 95 % CI = 3.127–60.69), sharing living quarters with domestic animals (aOR = 3.1; 95 % CI = 0.003–.046) and learning in classrooms with dusty floors (aOR = 14.657; 95 % CI = 2.262–94.95). Treatment of tungiasis was found to be mainly through mechanical removal of embedded T. penetrans.ConclusionThis study shows that tungiasis in the selected study areas of Kiharu constituency is a disease of significant health concern. Factors associated with tungiasis were identified that should be the focus of sustainable and effective control measures.

The present study evaluated the in vitro activity and in vivo efficacy of diminazene combined with chloroquine as a potential drug against Leishmania donovani. Amphotericin B was used as a positive control drug. In vitro activity involved incubation of various drug concentrations with promastigotes or vero cells in culture before determination of parasite growth inhibition or cell death while in vivo evaluations involved infection of various mice groups with virulent L. donovani parasites and treatment with test drug compounds following disease establishment. Weight changes in experimental mice were also evaluated before infection and throughout the experiment. The results indicated that the diminazene–chloroquine combination was at least nine times more efficacious than individual drugs in killing promastigotes in culture. The diminazene–chloroquine combination was safer (Ld50 = 0.03±0.04) than Amphotericin B (Ld50 = 0.02±0.01). Body weight in infected mice increased significantly (P = 0.0007) from day 7 to day 37 following infection (P = 0.026). However, body weight remained comparable in all mice groups during treatment (P = 0.16). The diminazene–chloroquine combination significantly reduced splenic parasite numbers as compared to individual drug therapies (P = 0.0001) although Amphotericin B was still more efficacious than any other treatment (P = 0.0001). Amongst the test compounds, the diminazene–chloroquine combination showed the lowest level of IgG antibody responses with results indicating significant negative correlation between antileishmanial antibody responses and protection against disease. These findings demonstrate the positive advantage and the potential use of a combined therapy of diminazene–chloroquine over the constituent drugs. Further evaluation is recommended to determine the most efficacious combination ratio of the two compounds.

BackgroundThe enumeration of absolute CD4 counts is of primary importance for many medical conditions especially HIV infection where therapeutic initiation depends on the count. These ranges tend to vary across populations. However, these ranges have not been comprehensively established in the Kenyan population. Therefore, this study aimed at establishing the reference ranges for the CD4 and CD8 T-lymphocytes in normal healthy individuals in Kenya.MethodsA total of 315 individuals of the ages between 16 and 60 years old, in 5 different regions of the country, were recruited into the study. They were screened for diseases that potentially cause lymphocyte homeostasis perturbation. CD4/CD8 Counts were performed by use of a FACSCalibur flow cytometer (Becton-Dickinson, NJ) equipped with automated acquisition and analysis software. Results were analysed according to age, sex and region.ResultsResults were presented as means and ranges (in parenthesis) generated non parametrically as 2.5 and 97.5 percentiles as follows; In general population; CD3 1655 (614-2685 cells/μL ), CD4 920 (343-1493 cells/μL), and CD8 646 (187-1139 cells/μL), while according to sex, females; CD3 1787 (697-2841 cells/μL), CD4 1010 (422-1572 cells/μL), CD8 659 (187-1180 cells/μL); males; CD3 1610 (581-2641 cells/μL), CD4 889(320-1459 cells/μL) and CD8 644 (185-1140 cells/μL). The general reference ranges for CD4/CD8 ratios were as follows; general population 1.57(0.50-2.74), males 1.51(0.49-2.64) and females 1.69(0.55-2.95).ConclusionThe lymphocyte reference ranges for the Kenyan population are fairly comparable to those established in other African populations. The ranges also differ appreciably from those established in Germany, Italy and Switzerland. Furthermore, the study reported significant differences in the ranges of different population clusters within Kenya, as well us between males and females.

Brucellosis in cattle is a zoonosis mainly caused by Brucella abortus. In Kenya, the disease is widespread, but its prevalence is largely unknown. The objective of this study was to investigate incidence rates of brucellosis and farmers' knowledge on the disease in Kahuro district, Murang'a County. In this study, 150 pooled milk samples were collected from 75 milk collection centers and tested. Subsequently, 230 milk samples were collected from farmers in 16 collection centers in Wangu and Mugoiri divisions whose pooled samples gave positive results. Five cow owners in each of the 16 collection centers were interviewed using a questionnaire to assess their knowledge levels. Wangu division had the highest incidence rate 19% with positive samples observed from 14 collection centers. Mugoiri division recorded 3% with two collection centers having positive samples, while Murarandia had none. All respondents with no formal education were unaware of the causative agent of brucellosis. There was a significant difference in incidence between Mugoiri and Wangu divisions (p < 0.05). Knowledge levels were high in the young and educated farmers compared to the old and uneducated. Frequent screening for brucellosis to identify infected animals should be initiated thus prevent transmission to other animals and humans.